Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Improving Translational Accuracy02:07

Improving Translational Accuracy

Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
Initiation of Translation02:33

Initiation of Translation

Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Improving Translational Accuracy02:07

Improving Translational Accuracy

Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
Translational Regulation01:29

Translational Regulation

Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proficiency order invariance of MLE, MAP, EAP, and WLE in item response theory.

The British journal of mathematical and statistical psychology·2026
Same author

A Self-Guided Web-Based Transdiagnostic Mental Health Program for People With Intellectual Disability: Single-Arm Trial.

JMIR formative research·2026
Same author

Improving the diagnosis of renal tumours of young people through integrated molecular analysis.

Journal of cancer research and clinical oncology·2026
Same author

PymiRa: A rapid and accurate classification tool for small non-coding RNAs, including microRNAs.

PLoS computational biology·2026
Same author

Droplet Digital PCR and Quantitative RT-PCR Comparison for Circulating miR-371a-3p in Malignant Germ Cell Tumors.

The Journal of molecular diagnostics : JMD·2026
Same author

Needs and Expectations for the myNewWay Blended Digital and Face-to-Face Psychotherapy Model of Care for Depression and Anxiety (Part 2): Participatory Design Study including Mental Health Professionals.

JMIR human factors·2025
Same journal

Escaping the trap.

Nature reviews. Cancer·2026
Same journal

A genomic and epigenomic lens into the biology of acute lymphoblastic leukaemia.

Nature reviews. Cancer·2026
Same journal

Systemic health impact of cancer-associated extracellular vesicles and particles.

Nature reviews. Cancer·2026
Same journal

Imaging the hallmarks of cancer.

Nature reviews. Cancer·2026
Same journal

CLIM-TIME links tumour genetics to spatial immune architecture.

Nature reviews. Cancer·2026
Same journal

Serving sulfur to boost anti-tumour immunity.

Nature reviews. Cancer·2026
See all related articles

Related Experiment Video

Updated: May 24, 2026

Quantitative Immunofluorescence to Measure Global Localized Translation
09:13

Quantitative Immunofluorescence to Measure Global Localized Translation

Published on: August 22, 2017

Translational approaches to improving cervical screening.

Peter Baldwin1, Ronald Laskey, Nicholas Coleman

  • 1MRC Cancer Cell Unit, Hutchison/MRC Research Centre, Hills Road, Cambridge CB2 2XZ, UK.

Nature Reviews. Cancer
|March 4, 2003
PubMed
Summary
This summary is machine-generated.

Cervical cancer screening with Pap smears has reduced disease rates but has limitations. New molecular approaches may improve accuracy and affordability for better clinical benefit.

More Related Videos

Cell Based Assays of SINEUP Non-coding RNAs That Can Specifically Enhance mRNA Translation
10:21

Cell Based Assays of SINEUP Non-coding RNAs That Can Specifically Enhance mRNA Translation

Published on: February 1, 2019

Generation and Genetic Manipulation of Human Cervical Organoids
10:29

Generation and Genetic Manipulation of Human Cervical Organoids

Published on: March 10, 2026

Related Experiment Videos

Last Updated: May 24, 2026

Quantitative Immunofluorescence to Measure Global Localized Translation
09:13

Quantitative Immunofluorescence to Measure Global Localized Translation

Published on: August 22, 2017

Cell Based Assays of SINEUP Non-coding RNAs That Can Specifically Enhance mRNA Translation
10:21

Cell Based Assays of SINEUP Non-coding RNAs That Can Specifically Enhance mRNA Translation

Published on: February 1, 2019

Generation and Genetic Manipulation of Human Cervical Organoids
10:29

Generation and Genetic Manipulation of Human Cervical Organoids

Published on: March 10, 2026

Area of Science:

  • Oncology
  • Molecular Biology
  • Public Health

Background:

  • Cervical cancer screening programs utilizing the Papanicolaou (Pap) smear have significantly decreased disease incidence.
  • However, the Pap smear test has limitations including suboptimal sensitivity and challenges in performance and cost.
  • Advances in understanding the molecular basis of cervical cancer are paving the way for improved screening strategies.

Purpose of the Study:

  • To explore novel screening approaches for cervical cancer.
  • To leverage advancements in molecular pathogenesis for enhanced diagnostic accuracy.
  • To investigate methods for more affordable and automatable cervical cancer screening.

Main Methods:

  • Review of current cervical cancer screening limitations.
  • Analysis of molecular pathways involved in cervical neoplasia.
  • Exploration of potential new screening technologies and biomarkers.

Main Results:

  • Current Pap smear screening, while effective, is limited in sensitivity and practicality.
  • Molecular insights into cervical cancer development offer opportunities for next-generation diagnostics.
  • New approaches promise increased accuracy, cost-effectiveness, and automation potential.

Conclusions:

  • Improved understanding of cervical cancer biology can drive innovation in screening.
  • Novel molecular screening methods hold the potential to overcome current test limitations.
  • Translating biological insights into clinical practice can significantly benefit patient outcomes.